Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan for Ischemic Digital Ulcers in Systemic Sclerosis
NCT01474122Phase 3Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of macitentan in Digital ulcer, sponsored by Actelion Pharmaceuticals Ltd. Started Dec 2011; status: terminated.
02
Drugs
macitentan
03
Conditions
Digital ulcer
Beyond the preview
Go deeper on NCT01474122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474122.